FY2025 EPS Estimates for DENTSPLY SIRONA Boosted by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at Barrington Research upped their FY2025 EPS estimates for DENTSPLY SIRONA in a research report issued to clients and investors on Monday, May 12th. Barrington Research analyst M. Petusky now forecasts that the medical instruments supplier will earn $1.90 per share for the year, up from their previous forecast of $1.86. Barrington Research currently has a “Outperform” rating and a $21.00 price objective on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Barrington Research also issued estimates for DENTSPLY SIRONA’s FY2026 earnings at $2.10 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. During the same period in the prior year, the firm earned $0.42 EPS. The firm’s quarterly revenue was down 7.8% on a year-over-year basis.

XRAY has been the subject of several other reports. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, May 9th. Piper Sandler decreased their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a report on Wednesday, April 30th. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Mizuho reduced their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research report on Thursday, March 13th. Finally, Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target for the company. in a report on Tuesday, April 15th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $20.36.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $16.60 on Wednesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.31 billion, a PE ratio of -8.02, a P/E/G ratio of 1.80 and a beta of 0.92. The firm has a 50 day simple moving average of $14.38 and a 200-day simple moving average of $17.48. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $28.57.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently bought and sold shares of XRAY. Bank of New York Mellon Corp grew its position in DENTSPLY SIRONA by 27.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after acquiring an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after purchasing an additional 35,360 shares during the period. Barclays PLC grew its holdings in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after purchasing an additional 54,920 shares in the last quarter. Canvas Wealth Advisors LLC increased its stake in DENTSPLY SIRONA by 126.5% during the 4th quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock worth $6,245,000 after buying an additional 182,234 shares during the period. Finally, Pallas Capital Advisors LLC acquired a new position in DENTSPLY SIRONA in the 4th quarter worth $264,000. 95.70% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.86%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.